ASSEMBLY BIOSCIENCES, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Assembly Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Assembly Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$11.2M, a 34% increase year-over-year.
  • Assembly Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$45.6M, a 44% increase year-over-year.
  • Assembly Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$61.2M, a 34.2% increase from 2022.
  • Assembly Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$93.1M, a 28.3% increase from 2021.
  • Assembly Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$130M, a 109% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$45.6M -$11.2M +$5.74M +34% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$51.4M -$9.08M +$9.87M +52.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$61.2M -$11M +$11.4M +51.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$72.7M -$14.4M +$8.73M +37.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$81.4M -$16.9M +$7.57M +30.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$89M -$19M +$4.14M +17.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$93.1M -$22.4M +$37.9M +62.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$131M -$23.1M -$4.34M -23.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$127M -$24.5M -$866K -3.67% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$126M -$23.1M +$4.11M +15.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$130M -$60.3M -$20.8M -52.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$109M -$18.8M -$15.5M -461% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$93.6M -$23.6M -$30.9M -425% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$62.7M -$27.2M -$545K -2.05% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$62.2M -$39.4M -$12.3M -45.5% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-25
Q3 2020 -$49.8M -$3.35M +$21.6M +86.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$71.5M $7.27M +$25.8M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$97.2M -$26.7M +$397K +1.47% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$97.6M -$27.1M -$923K -3.53% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$96.7M -$25M -$3.46M -16.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 -$93.3M -$18.5M +$8.3M +31% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 -$102M -$27.1M -$10.8M -66.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 -$90.8M -$26.2M -$23.2M -770% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 -$67.6M -$21.5M -$9.26M -75.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-04
Q2 2018 -$58.3M -$26.8M -$13.2M -97.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-04
Q1 2018 -$45.1M -$16.2M -$2.32M -16.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-04
Q4 2017 -$42.8M -$3.01M +$8.54M +74% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$51.3M -$12.3M -$698K -6.03% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$50.7M -$13.6M -$3.45M -34% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$47.2M -$13.9M -$2.94M -26.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$44.3M -$11.5M -$3.8M -49% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 -$40.5M -$11.6M -$4.96M -74.9% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-08
Q2 2016 -$35.5M -$10.2M -$3.21M -46.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-08
Q1 2016 -$32.3M -$11M -$3.84M -53.8% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-08
Q4 2015 -$28.5M -$7.75M -$1.52M -24.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-02
Q3 2015 -$26.9M -$6.62M +$4.4M +39.9% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-02
Q2 2015 -$31.3M -$6.94M -$4.47M -181% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-02
Q1 2015 -$26.9M -$7.14M -$3.08M -75.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-02
Q4 2014 -$23.8M -$6.23M -$182K -3.02% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 -$23.6M -$11M -$6.14M -126% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$17.5M -$2.47M +$2.28M +48% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$19.8M -$4.07M -$347K -9.32% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$19.4M -$6.05M -$2.26M -59.5% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-03-16
Q3 2013 -$17.1M -$4.88M +$474K +8.84% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-17
Q2 2013 -$17.6M -$4.75M +$2.72M +36.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$20.3M -$3.72M +$4.45M +54.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$24.8M -$3.79M +$15.1M +79.9% Oct 1, 2012 Dec 31, 2012 10-K 2013-03-18
Q3 2012 -$39.9M -$5.36M +$446K +7.69% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$40.3M -$7.47M -$509K -7.31% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$39.8M -$8.17M -$5.45M -200% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$34.3M -$18.9M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$5.8M -$4.03M -227% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 -$6.96M -$4.83M -227% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 -$2.72M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 -$1.78M Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-11-18
Q2 2010 -$2.13M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.